163 related articles for article (PubMed ID: 17387473)
21. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
[TBL] [Abstract][Full Text] [Related]
22. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
23. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
24. The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers.
Sun DS; Zhao MQ; Xia M; Li L; Jiang YH
Med Oncol; 2012 Jun; 29(2):707-13. PubMed ID: 21424865
[TBL] [Abstract][Full Text] [Related]
25. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
[TBL] [Abstract][Full Text] [Related]
26. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside TL
Cell Immunol; 1997 Apr; 177(1):35-48. PubMed ID: 9140094
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
28. Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
Califano JA; Khan Z; Noonan KA; Rudraraju L; Zhang Z; Wang H; Goodman S; Gourin CG; Ha PK; Fakhry C; Saunders J; Levine M; Tang M; Neuner G; Richmon JD; Blanco R; Agrawal N; Koch WM; Marur S; Weed DT; Serafini P; Borrello I
Clin Cancer Res; 2015 Jan; 21(1):30-8. PubMed ID: 25564570
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
30. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
Sun W; Li WJ; Wu CY; Zhong H; Wen WP
J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
[TBL] [Abstract][Full Text] [Related]
31. Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck.
Shirai A; Furukawa M; Yoshizaki T
Laryngoscope; 2003 Nov; 113(11):1955-60. PubMed ID: 14603055
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
33. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
Drennan S; Stafford ND; Greenman J; Green VL
Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
[TBL] [Abstract][Full Text] [Related]
34. Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.
Wang XM; Wu TX; Hamza M; Ramsay ES; Wahl SM; Dionne RA
Pain; 2007 Mar; 128(1-2):136-47. PubMed ID: 17070997
[TBL] [Abstract][Full Text] [Related]
35. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
[TBL] [Abstract][Full Text] [Related]
36. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.
Kerrebijn JD; Simons PJ; Tas M; Balm AJ; Drexhage HA
Eur Arch Otorhinolaryngol; 1995; 252(7):409-16. PubMed ID: 8562036
[TBL] [Abstract][Full Text] [Related]
37. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
38. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
39. Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes.
Balm FJ; Drexhage HA; von Blomberg ME; Snow GB
Laryngoscope; 1982 Jul; 92(7 Pt 1):810-4. PubMed ID: 7087651
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
